Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES CIPLA ZYDUS LIFESCIENCES/
CIPLA
 
P/E (TTM) x 34.2 32.2 106.2% View Chart
P/BV x 5.8 5.2 111.7% View Chart
Dividend Yield % 0.6 0.6 105.0%  

Financials

 ZYDUS LIFESCIENCES   CIPLA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
CIPLA
Mar-23
ZYDUS LIFESCIENCES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4951,185 41.8%   
Low Rs319852 37.5%   
Sales per share (Unadj.) Rs170.3281.9 60.4%  
Earnings per share (Unadj.) Rs19.835.1 56.3%  
Cash flow per share (Unadj.) Rs26.949.7 54.2%  
Dividends per share (Unadj.) Rs6.008.50 70.6%  
Avg Dividend yield %1.50.8 176.6%  
Book value per share (Unadj.) Rs173.0289.2 59.8%  
Shares outstanding (eoy) m1,012.20807.15 125.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.43.6 66.2%   
Avg P/E ratio x20.629.0 71.0%  
P/CF ratio (eoy) x15.120.5 73.7%  
Price / Book Value ratio x2.43.5 66.8%  
Dividend payout %30.324.2 125.4%   
Avg Mkt Cap Rs m412,144822,164 50.1%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56438,301 64.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374227,531 75.8%  
Other income Rs m4,7465,121 92.7%   
Total revenues Rs m177,120232,653 76.1%   
Gross profit Rs m29,67748,079 61.7%  
Depreciation Rs m7,22711,721 61.7%   
Interest Rs m1,2991,095 118.6%   
Profit before tax Rs m25,89740,384 64.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,87812,029 48.9%   
Profit after tax Rs m20,01928,355 70.6%  
Gross profit margin %17.221.1 81.5%  
Effective tax rate %22.729.8 76.2%   
Net profit margin %11.612.5 93.2%  
BALANCE SHEET DATA
Current assets Rs m100,082168,051 59.6%   
Current liabilities Rs m55,26750,333 109.8%   
Net working cap to sales %26.051.7 50.3%  
Current ratio x1.83.3 54.2%  
Inventory Days Days5073 68.6%  
Debtors Days Days947 1,437.1%  
Net fixed assets Rs m144,776117,318 123.4%   
Share capital Rs m1,0121,614 62.7%   
"Free" reserves Rs m174,146231,845 75.1%   
Net worth Rs m175,158233,460 75.0%   
Long term debt Rs m00-   
Total assets Rs m244,940290,067 84.4%  
Interest coverage x20.937.9 55.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 89.7%   
Return on assets %8.710.2 85.7%  
Return on equity %11.412.1 94.1%  
Return on capital %15.517.8 87.4%  
Exports to sales %39.222.6 173.2%   
Imports to sales %11.98.9 134.2%   
Exports (fob) Rs m67,57751,516 131.2%   
Imports (cif) Rs m20,54420,202 101.7%   
Fx inflow Rs m67,57764,282 105.1%   
Fx outflow Rs m20,54420,202 101.7%   
Net fx Rs m47,03344,080 106.7%   
CASH FLOW
From Operations Rs m26,88832,377 83.0%  
From Investments Rs m11,712-23,885 -49.0%  
From Financial Activity Rs m-44,004-9,583 459.2%  
Net Cashflow Rs m-5,338-968 551.6%  

Share Holding

Indian Promoters % 75.0 13.4 558.3%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 18.0 50.0 36.1%  
FIIs % 5.0 25.7 19.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 66.5 37.6%  
Shareholders   306,495 425,731 72.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Cadila Healthcare vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Cipla Share Price Performance

Period Cadila Healthcare Cipla S&P BSE HEALTHCARE
1-Day 0.57% 1.94% 1.18%
1-Month 7.77% 1.25% -0.75%
1-Year 107.52% 68.02% 61.82%
3-Year CAGR 32.30% 22.53% 18.16%
5-Year CAGR 24.52% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.